BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17212863)

  • 21. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
    Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
    Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study.
    Cowan FM; Humphrey JH; Ntozini R; Mutasa K; Morrow R; Iliff P
    AIDS; 2008 Jan; 22(2):193-201. PubMed ID: 18097221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival of HIV-infected treatment-naive individuals with documented dates of seroconversion in Rakai, Uganda.
    Lutalo T; Gray RH; Wawer M; Sewankambo N; Serwadda D; Laeyendecker O; Kiwanuka N; Nalugoda F; Kigozi G; Ndyanabo A; Bwanika JB; Reynolds SJ; Quinn T; Opendi P
    AIDS; 2007 Nov; 21 Suppl 6():S15-9. PubMed ID: 18032934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pregnancy and the risk of HIV-1 acquisition among women in Uganda and Zimbabwe.
    Morrison CS; Wang J; Van Der Pol B; Padian N; Salata RA; Richardson BA
    AIDS; 2007 May; 21(8):1027-34. PubMed ID: 17457097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.
    Ekouevi DK; Coffie PA; Becquet R; Tonwe-Gold B; Horo A; Thiebaut R; Leroy V; Blanche S; Dabis F; Abrams EJ
    AIDS; 2008 Sep; 22(14):1815-20. PubMed ID: 18753864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Availability and Use of ART/PMTCT Services on Fertility Desires of Previously Pregnant Women in Rakai, Uganda: A Retrospective Cohort Study.
    Litwin LE; Makumbi FE; Gray R; Wawer M; Kigozi G; Kagaayi J; Nakigozi G; Lutalo T; Serwada D; Brahmbhatt H
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):377-84. PubMed ID: 25835605
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCV/HIV co-infection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus?
    Mariné-Barjoan E; Berrébi A; Giordanengo V; Favre SF; Haas H; Moreigne M; Izopet J; Tricoire J; Tran A; Pradier C; Bongain A
    AIDS; 2007 Aug; 21(13):1811-5. PubMed ID: 17690581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention of vertical transmission of HIV in Denmark].
    Rasmussen MB; Rasmussen JB; Nielsen VR; Herlin T; Fisker N; Hornstrup MK; Vinter H; Olofsson M; Weis NM
    Ugeskr Laeger; 2008 Aug; 170(34):2567-70. PubMed ID: 18761841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA; Ekouevi DK; Chaix ML; Tonwe-Gold B; Clarisse AB; Becquet R; Viho I; N'dri-Yoman T; Leroy V; Abrams EJ; Rouzioux C; Dabis F
    Clin Infect Dis; 2008 Feb; 46(4):611-21. PubMed ID: 18197758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    ; Arrivé E; Chaix ML; Nerrienet E; Blanche S; Rouzioux C; Coffie PA; Kruy Leang S; McIntyre J; Avit D; Srey VH; Gray G; N'Dri-Yoman T; Diallo A; Ekouévi DK; Dabis F
    AIDS; 2009 Apr; 23(7):825-33. PubMed ID: 19307941
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of human immunodeficiency virus mother-to-child transmission in Israel.
    Agmon-Levin N; Elbirt D; Asher I; Torten D; Cohen Y; Gradestein S; Werner B; Turner D; Chowers M; Gottesman G; Maayan S; Risenberg K; Levi I; Sthoeger Z
    Int J STD AIDS; 2009 Jul; 20(7):473-6. PubMed ID: 19541889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preterm delivery risk in relation to maternal HIV infection, history of malaria and other infections among urban Zimbabwean women.
    Noble A; Ning Y; Woelk GB; Mahomed K; Williams MA
    Cent Afr J Med; 2005; 51(5-6):53-8. PubMed ID: 17432432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amniocentesis in pregnant HIV-infected patients. Absence of mother-to-child viral transmission in a series of selected patients.
    Ekoukou D; Khuong-Josses MA; Ghibaudo N; Mechali D; Rotten D
    Eur J Obstet Gynecol Reprod Biol; 2008 Oct; 140(2):212-7. PubMed ID: 18584937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.
    Lopez-Cortes LF; Ruiz-Valderas R; Rivero A; Camacho A; Marquez-Solero M; Santos J; García-Lazaro M; Viciana P; Rodriguez-Baños J; Ocampo A
    Ther Drug Monit; 2007 Apr; 29(2):171-6. PubMed ID: 17417070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morbidity and mortality patterns in HIV-1 seropositive/ seronegative women in Kampala and Harare during pregnancy and in the subsequent two years.
    Mbizvo MT; Mmiro FA; Kasule J; Bagenda D; Mahomed K; Nathoo K; Mirembe F; Choto R; Nakabiito C; Ndugwa CM; Meirik O
    Cent Afr J Med; 2005; 51(9-10):91-7. PubMed ID: 17427876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gestational diabetes mellitus in a cohort of HIV-1 infected women.
    González-Tomé MI; Ramos Amador JT; Guillen S; Solís I; Fernández-Ibieta M; Muñoz E; Almeda J; Rojano X; Rojo P; Nieto O;
    HIV Med; 2008 Nov; 9(10):868-74. PubMed ID: 18983478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mother-to-child transmission of HIV-1: association with malaria prevention, anaemia and placental malaria.
    Naniche D; Lahuerta M; Bardaji A; Sigauque B; Romagosa C; Berenguera A; Mandomando I; David C; Sanz S; Aponte J; Ordi J; Alonso P; Menendez C
    HIV Med; 2008 Oct; 9(9):757-64. PubMed ID: 18651857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.